Cellyan Biotechnology Co., Ltd
NASDAQ: HKPD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Chenyu Liang
- Employees
- 27
- Headquarters
- Yau Tong, Hong Kong SAR China
- IPO year
- 2025
- Market cap
- $4.3M
- Website
- http://www.9zt.hk
Loading HKPD…
Loading profile data…Frequently asked questions about HKPD
What does Cellyan Biotechnology Co., Ltd (HKPD) do?
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management....
Where does HKPD trade?
Cellyan Biotechnology Co., Ltd (HKPD) trades on the NASDAQ Capital Market.
What sector is HKPD in?
Cellyan Biotechnology Co., Ltd (HKPD) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Cellyan Biotechnology Co., Ltd?
Chenyu Liang is the chief executive officer of Cellyan Biotechnology Co., Ltd (HKPD).
Where is Cellyan Biotechnology Co., Ltd headquartered?
Cellyan Biotechnology Co., Ltd is headquartered in Hong Kong SAR China.
Does HKPD pay a dividend?
Cellyan Biotechnology Co., Ltd (HKPD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HKPD go public?
Cellyan Biotechnology Co., Ltd (HKPD) completed its initial public offering in 2025.